KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on May 19, 2026 - 9:51AM >>  ABB India 6418.05  [ 0.56% ]  ACC 1359.3  [ -0.37% ]  Ambuja Cements 430.05  [ -0.86% ]  Asian Paints 2612.75  [ 0.28% ]  Axis Bank 1238.4  [ -0.52% ]  Bajaj Auto 10198.65  [ -1.73% ]  Bank of Baroda 260.1  [ -0.54% ]  Bharti Airtel 1938.1  [ 1.76% ]  Bharat Heavy 395.15  [ -0.77% ]  Bharat Petroleum 280.85  [ -1.25% ]  Britannia Industries 5377.3  [ -0.51% ]  Cipla 1426.6  [ -0.35% ]  Coal India 461.95  [ -0.04% ]  Colgate Palm 2152.75  [ -0.32% ]  Dabur India 456.65  [ -2.26% ]  DLF 573.25  [ 1.10% ]  Dr. Reddy's Lab. 1331.4  [ -0.42% ]  GAIL (India) 160.2  [ -1.42% ]  Grasim Industries 2943.65  [ 0.42% ]  HCL Technologies 1146.8  [ 1.24% ]  HDFC Bank 768.55  [ 0.10% ]  Hero MotoCorp 4956.1  [ -2.16% ]  Hindustan Unilever 2254.9  [ -0.71% ]  Hindalco Industries 1052.55  [ -1.38% ]  ICICI Bank 1250.95  [ 0.50% ]  Indian Hotels Co. 648.25  [ -1.06% ]  IndusInd Bank 892.45  [ 0.58% ]  Infosys 1142.4  [ 2.15% ]  ITC 310.15  [ 0.21% ]  Jindal Steel 1231.9  [ 0.02% ]  Kotak Mahindra Bank 391.7  [ 1.14% ]  L&T 3918.95  [ 0.29% ]  Lupin 2253  [ -0.92% ]  Mahi. & Mahi 3083.25  [ -1.26% ]  Maruti Suzuki India 13014.75  [ -1.60% ]  MTNL 28.67  [ -1.82% ]  Nestle India 1432.4  [ 0.15% ]  NIIT 61.81  [ -3.03% ]  NMDC 90.15  [ -1.39% ]  NTPC 387.6  [ -1.86% ]  ONGC 297.2  [ -0.75% ]  Punj. NationlBak 99.55  [ -2.45% ]  Power Grid Corpn. 296.45  [ -3.07% ]  Reliance Industries 1335.2  [ -0.09% ]  SBI 940  [ -2.38% ]  Vedanta 326.9  [ -1.27% ]  Shipping Corpn. 344.65  [ 4.11% ]  Sun Pharmaceutical 1905.2  [ 1.34% ]  Tata Chemicals 730  [ -2.53% ]  Tata Consumer 1230.8  [ -0.28% ]  Tata Motors Passenge 353  [ -1.00% ]  Tata Steel 209.85  [ -3.21% ]  Tata Power Co. 404.4  [ -0.68% ]  Tata Consult. Serv. 2284.2  [ 0.90% ]  Tech Mahindra 1430.45  [ 4.39% ]  UltraTech Cement 11550  [ 0.52% ]  United Spirits 1315.2  [ -0.38% ]  Wipro 192.2  [ 1.18% ]  Zee Entertainment 84.65  [ -4.34% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

ALIVUS LIFE SCIENCES LTD.

19 May 2026 | 09:34

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE03Q201024 BSE Code / NSE Code 543322 / ALIVUS Book Value (Rs.) 257.91 Face Value 2.00
Bookclosure 01/09/2025 52Week High 1155 EPS 45.99 P/E 22.94
Market Cap. 12947.78 Cr. 52Week Low 819 P/BV / Div Yield (%) 4.09 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
The Company was incorporated as `Zorg Laboratories Private Limited', a private limited company under the Companies Act, 1956 on June 23, 2011 at Pune and was granted the certificate of incorporation by the RoC. the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated July 4, 2018. For further details, please see - "Details regarding material acquisitions or divestments of business/ undertakings, mergers, amalgamations or any revaluation of assets, in the last 10 years - Acquisition by Glenmark Pharmaceuticals Limited" on page 151. Pursuant to the acquisition, the name of the Company was changed to `Glenmark Life Sciences Private Limited' by way of a special resolution passed by the shareholders of the Company on July 25, 2018 and a fresh certificate of incorporation dated August 10, 2018 was issued by the RoC. A shareholders' resolution was passed on August 13, 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated August 28, 2018 was issued by the RoC. Thereafter, the business of active pharmaceutical ingredients was acquired by the Company from the Promoter pursuant to the Business Purchase Agreement.

Major events and milestones of the Company :
2002
- The Promoter established its API business
- Established manufacturing plant at Kurkumbh, Maharashtra

2003
- First product registered with US-FDA
- Acquired GlaxoSmithKline's (GSK) API manufacturing plant in Ankleshwar, Gujarat

2004
- Commenced manufacturing at Mohol, Maharashtra

2008
- Ankleshwar plant at Gujarat inspected by US-FDA

2012
- Ankleshwar plant inspected by PMDA and AFSSAPS

2013
- Commenced manufacturing at Dahej, Gujarat
- Ankleshwar plant inspected by COFEPRIS

2015
- Dahej plant inspected by US-FDA

2016
- Dahej plant inspected by PMDA Japan

2018
- Dahej plant inspected by EDQM, ANSM and US-FDA
- Mohol plant inspected by US-FDA

2019
- The API business was spun off into the Company
- Ankleshwar plant inspected by US-FDA, Health Canada and PMDA, Japan

2021
- Achieved milestone of 403 cumulative drug master files (DMF) registrations across multiple markets globally

2023 -The Company had announced that its board had given the green light to divest a 75% stake in its subsidiary GLS to Nirma Ltd for a total of Rs 5,651.5 crore.

2025 -The Company name has changed from Glenmark Life Sciences Ltd to Alivus Life Sciences Ltd. -The Company Informed regarding Agreement and Power Supply Agreement between Alivus Life Sciences Ltd. and Torrent Urja 19 Private Ltd.